Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach
- 8 May 2007
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (19) , 8065-8070
Abstract
Fabry disease is a disorder of alpha-D-galactosyl-containing glycolipids resulting from a deficiency of alpha-galactosidase A. Patients have a poorly understood vascular dysregulation. We hypothesized that disease-related perturbation by using enzyme replacement therapy in the murine model of Fabry disease would provide insight into abnormal biological processes in Fabry disease. Gene expression analyses of the heart, aorta, and liver of male alpha-galactosidase A knockout mice 28 weeks of age were compared with that of WT mice. Microarray analyses were performed before and after six weekly injections of a-galactosidase A. Alteration of Rpgrip1 ranked highest statistically in all three organs when knockout mice were compared with WT, and its splice variants responded in a unique way to alpha-galactosidase A. Enzyme replacement therapy tended to not only normalize gene expression, e.g., reduce the overexpression of securin, but also specifically modified gene expression in each tissue examined. Following multiple comparison analysis, gene expression correlation graphs were constructed, and a priori hypotheses were examined by using structural equation modeling. This systems biology approach demonstrated multiple and complex parallel cellular abnormalities in Fabry disease. These abnormalities form the basis for informed, in a Bayesian sense, sequential, hypothesis-driven research that can be subsequently tested experimentally.Keywords
This publication has 36 references indexed in Scilit:
- Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalitiesProceedings of the National Academy of Sciences, 2007
- α-Galactosidase A Deficiency Leads to Increased Tissue Fibrin Deposition and Thrombosis in Mice Homozygous for the Factor V Leiden MutationStroke, 2006
- Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanismsHuman Molecular Genetics, 2005
- AntiplasminThe FEBS Journal, 2005
- Limited proteolysis differentially modulates the stability and subcellular localization of domains of RPGRIP1 that are distinctly affected by mutations in Leber's congenital amaurosisHuman Molecular Genetics, 2005
- ObituaryOncogene, 2004
- Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous systemThrombosis and Haemostasis, 2004
- Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilizationNature, 2002
- A family of mammalian F-box proteinsCurrent Biology, 1999
- Reporting structural equation modeling results in Psychology and Aging: Some proposed guidelines.Psychology and Aging, 1991